Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
November-2020 Volume 20 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
November-2020 Volume 20 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

CGA ameliorates cognitive decline by regulating the PI3K/AKT signaling pathway and neurotransmitter systems in rats with multi-infarct dementia

  • Authors:
    • Ying Fu
    • Jiangping Wei
    • Bin Li
    • Lijuan Gao
    • Peng Xia
    • Yueqiang Wen
    • Shijun Xu
  • View Affiliations / Copyright

    Affiliations: School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan 611137, P.R. China, Institute of Meterial Medica Integration and Transformation for Brain Disorders, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan 611137, P.R. China
    Copyright: © Fu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 70
    |
    Published online on: September 9, 2020
       https://doi.org/10.3892/etm.2020.9198
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Multi infarct dementia (MID) is a form of dementia that is preventable and treatable. However, at present, the drugs used in MID treatment were developed for Alzheimer's disease. While only a limited range of drugs is available, the incidence of MID is increasing year on year. The present study aimed to investigate the effect and underlying mechanisms of a combination of ginsenosides and astragalosides (CGA) on cognitive decline in rats with MID. A rat model of MID was established using micro‑thromboembolism, and the behavioral changes in the rats were evaluated using the Morris water maze and open field tests at 60 days post‑CGA intervention. The pathological morphology of the hippocampal CA1 area was observed using hematoxylin and eosin staining. The contents of ATP, ADP and AMP were determined using high‑performance liquid chromatography. Mitochondrial swelling and changes in the membrane potential in the hippocampus were detected using flow cytometry, and the changes in insulin, glutamate and γ‑aminobutyric acid (GABA) content were detected using ELISA. Additionally, the expression of PI3K and AKT proteins was detected using western blot analysis. In a rat model of MID, CGA shortened the escape latency, increased the frequency of platform crossing, improved the disordered vertebral cell arrangement and reduced the cell number in the hippocampal CA1 area. CGA also reduced the degree of mitochondrial swelling, increased the mitochondrial membrane potential, and elevated the energy load and ATP content in the brain of rats with MID. Furthermore, CGA increased the insulin content and upregulated the expression of PI3K and AKT in the brain of rats with MID. In addition, in the rat model of MID, CGA also enhanced the movement time and the frequency of standing, and decreased the concentration of glutamate and GABA in the brain tissue. Amelioration of the cognitive decline in rats with MID by CGA was associated with its regulatory effect on the PI3K/AKT signaling pathway and neurotransmitter systems.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

View References

1 

Iadecola C: The pathobiology of vascular dementia. Neuron. 80:844–866. 2013.PubMed/NCBI View Article : Google Scholar

2 

Iadecola C: Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat Rev Neurosci. 5:347–360. 2004.PubMed/NCBI View Article : Google Scholar

3 

Harris JJ, Jolivet R and Attwell D: Synaptic energy use and supply. Neuron. 75:762–777. 2012.PubMed/NCBI View Article : Google Scholar

4 

Stefansdottir H, Arnar DO, Aspelund T, Sigurdsson S, Jonsdottir MK, Hjaltason H, Launer LJ and Gudnason V: Atrial fibrillation is associated with reduced brain volume and cognitive function independent of cerebral infarcts. Stroke. 44:1020–1025. 2013.PubMed/NCBI View Article : Google Scholar

5 

Marshall RS: Effects of altered cerebral hemodynamics on cognitive function. J Alzheimers Dis. 32:633–642. 2012.PubMed/NCBI View Article : Google Scholar

6 

de la Torre JC: Cerebral hemodynamics and vascular risk factors: Setting the stage for Alzheimer's disease. J Alzheimers Dis. 32:553–567. 2012.PubMed/NCBI View Article : Google Scholar

7 

Qian J, Wolters FJ, Beiser A, Haan M, Ikram MA, Karlawish J, Langbaum JB, Neuhaus JM, Reiman EM, Roberts JS, et al: APOE-related risk of mild cognitive impairment and dementia for prevention trials: An analysis of four cohorts. PLoS Med. 14(e1002254)2017.PubMed/NCBI View Article : Google Scholar

8 

Tian J, Fu F, Geng M, Jiang Y, Yang J, Jiang W, Wang C and Liu K: Neuroprotective effect of 20(S)-ginsenoside Rg3 on cerebral ischemia in rats. Neurosci Lett. 374:92–97. 2005.PubMed/NCBI View Article : Google Scholar

9 

Feng Y, Zhang W and Guo J: The alterations of brain lactate, lactate dehydrogenase, creatine phosphokinase and its influence on these of peripheral blood or liver tissue and entero-barrier during brain hypoperfusion. Zhongguo Bing Li Sheng Li Xue Hui. 12:1106–1109. 1999.(In Chinese).

10 

van der Bliek AM, Sedensky MM and Morgan PG: Cell Biology of the Mitochondrion. Genetics. 207:843–871. 2017.PubMed/NCBI View Article : Google Scholar

11 

Parihar MS and Brewer GJ: Amyloid-β as a modulator of synaptic plasticity. J Alzheimers Dis. 22:741–763. 2010.PubMed/NCBI View Article : Google Scholar

12 

Li H, Liu Y, Lin LT, Wang XR, Du SQ, Yan CQ, He T, Yang JW and Liu CZ: Acupuncture reversed hippocampal mitochondrial dysfunction in vascular dementia rats. Neurochem Int. 92:35–42. 2016.PubMed/NCBI View Article : Google Scholar

13 

Park YS, Choi SE and Koh HC: PGAM5 regulates PINK1/Parkin-mediated mitophagy via DRP1 in CCCP-induced mitochondrial dysfunction. Toxicol Lett. 284:120–128. 2018.PubMed/NCBI View Article : Google Scholar

14 

Wan Q, Ma X, Zhang ZJ, Sun T, Xia F, Zhao G and Wu YM: Ginsenoside reduces cognitive impairment during chronic cerebral hypoperfusion through brain-derived neurotrophic factor regulated by epigenetic modulation. Mol Neurobiol. 54:2889–2900. 2017.PubMed/NCBI View Article : Google Scholar

15 

1Dong X, Zheng L, Lu S and Yang Y: Neuroprotective effects of pretreatment of ginsenoside Rb1 on severe cerebral ischemia-induced injuries in aged mice: Involvement of anti-oxidant signaling. Geriatr Gerontol Int. 17:338–345. 2017.PubMed/NCBI View Article : Google Scholar

16 

Tang B, Wang D, Li M, Wu Q, Yang Q, Shi W and Chen C: An in vivo study of hypoxia-inducible factor-1α signaling in ginsenoside Rg1-mediated brain repair after hypoxia/ischemia brain injury. Pediatr Res. 81:120–126. 2017.PubMed/NCBI View Article : Google Scholar

17 

Li M, Li H, Fang F, Deng X and Ma S: Astragaloside IV attenuates cognitive impairments induced by transient cerebral ischemia and reperfusion in mice via anti-inflammatory mechanisms. Neurosci Lett. 639:114–119. 2017.PubMed/NCBI View Article : Google Scholar

18 

Zong W, Zeng X, Chen S, Chen L, Zhou L, Wang X, Gao Q, Zeng G, Hu K and Ouyang D: Ginsenoside compound K attenuates cognitive deficits in vascular dementia rats by reducing the Aβ deposition. J Pharmacol Sci. 139:223–230. 2019.PubMed/NCBI View Article : Google Scholar

19 

Zhang G, Liu A, Zhou Y, San X, Jin T and Jin Y: Panax ginseng ginsenoside-Rg2 protects memory impairment via anti-apoptosis in a rat model with vascular dementia. J Ethnopharmacol. 115:441–448. 2008.PubMed/NCBI View Article : Google Scholar

20 

Chang CP, Liu YF, Lin HJ, Hsu CC, Cheng BC, Liu WP, Lin MT, Hsu SF, Chang LS and Lin KC: Beneficial effect of astragaloside on Alzheimer's disease condition using cultured primary cortical cells under β-amyloid exposure. Mol Neurobiol. 53:7329–7340. 2016.PubMed/NCBI View Article : Google Scholar

21 

Li WZ, Wu WY, Huang DK, Yin YY, Kan HW, Wang X, Yao YY and Li WP: Protective effects of astragalosides on dexamethasone and Aβ25-35 induced learning and memory impairments due to decrease amyloid precursor protein expression in 12-month male rats. Food Chem Toxicol. 50:1883–1890. 2012.PubMed/NCBI View Article : Google Scholar

22 

Zhang Y, Su H, Zhang J and Kong J: The effects of ginsenosides and anserine on the up-regulation of renal aquaporins 1-4 in hyperuricemic mice. Am J Chin Med. 47:1133–1147. 2019.PubMed/NCBI View Article : Google Scholar

23 

Qiu LH, Zhang BQ, Lian MJ, Xie XJ and Chen P: Vascular protective effects of and its main constituents in rats with chronic hyperhomocysteinemia. Exp Ther Med. 14:2401–2407. 2017.PubMed/NCBI View Article : Google Scholar

24 

Yang JW, Wang XR, Ma SM, Yang NN, Li QQ and Liu CZ: Acupuncture attenuates cognitive impairment, oxidative stress and NF-κB activation in cerebral multi-infarct rats. Acupunct Med. 37:283–291. 2019.PubMed/NCBI View Article : Google Scholar

25 

Zhang X, Wu B, Nie K, Jia Y and Yu J: Effects of acupuncture on declined cerebral blood flow, impaired mitochondrial respiratory function and oxidative stress in multi-infarct dementia rats. Neurochem Int. 65:23–29. 2014.PubMed/NCBI View Article : Google Scholar

26 

Ying S, Lai X, Guan C, Xie LL, Wu LN and Tang CZ: Effect of electroacupuncture on learning-memory ability of vascular dementia rats with concomitant hypertension and hyperlipemia. Zhen Ci Yan Jiu. 34:368–375. 2009.(In Chinese). PubMed/NCBI

27 

Lin C, Jiang F, Peng T, et al: Toxicity test of zsydo on rabbit embryo fetal development//2015 (fifth) annual meeting of pharmacotoxicology.

28 

Ren X, Wei J and Gong D: Tongluoxingnao effervescent tablets ameliorate learning and memory impairment in a rat model of vascular dementia via the regulation of the p38 and ERK MAPK signaling pathways. Int J Clin Exp Med. 9:5400–5412. 2016.

29 

Smith EE: Clinical presentations and epidemiology of vascular dementia. Clin Sci (Lond). 131:1059–1068. 2017.PubMed/NCBI View Article : Google Scholar

30 

O'Brien JT and Thomas A: Vascular dementia. Lancet. 386:1698–1706. 2015.PubMed/NCBI View Article : Google Scholar

31 

Gubandru M, Margina D, Tsitsimpikou C, Goutzourelas N, Tsarouhas K, Ilie M, Tsatsakis AM and Kouretas D: Alzheimer's disease treated patients showed different patterns for oxidative stress and inflammation markers. Food Chem Toxicol. 61:209–214. 2013.PubMed/NCBI View Article : Google Scholar

32 

Bagheri G, Rezaee R, Tsarouhas K, Docea AO, Shahraki J, Shahriari M, Wilks MF, Jahantigh H, Tabrizian K, Moghadam AA, et al: Magnesium sulfate ameliorates carbon monoxide induced cerebral injury in male rats. Mol Med Rep. 19:1032–1039. 2019.PubMed/NCBI View Article : Google Scholar

33 

Arvanitakis Z, Leurgans SE, Barnes LL, Bennett DA and Schneider JA: Microinfarct pathology, dementia, and cognitive systems. Stroke. 42:722–727. 2011.PubMed/NCBI View Article : Google Scholar

34 

Ferrari C, Nacmias B and Sorbi S: The diagnosis of dementias: A practical tool not to miss rare causes. Neurol Sci. 39:615–627. 2018.PubMed/NCBI View Article : Google Scholar

35 

Kaneko D, Nakamura N and Ogawa T: Cerebral infarction in rats using homologous blood emboli: Development of a new experimental model. Stroke. 16:76–84. 1985.PubMed/NCBI View Article : Google Scholar

36 

Hou K, Xu D, Li F, Chen S and Li Y: The progress of neuronal autophagy in cerebral ischemia stroke: Mechanisms, roles and research methods. J Neurol Sci. 400:72–82. 2019.PubMed/NCBI View Article : Google Scholar

37 

Yang L, Wang H, Liu L and Xie A: The role of insulin/IGF-1/PI3K/Akt/GSK3β signaling in Parkinson's disease dementia. Front Neurosci. 12(73)2018.PubMed/NCBI View Article : Google Scholar

38 

Peng J, Pang J, Huang L, Enkhjargal B, Zhang T, Mo J, Wu P, Xu W, Zuo Y, Peng J, et al: LRP1 activation attenuates white matter injury by modulating microglial polarization through Shc1/PI3K/Akt pathway after subarachnoid hemorrhage in rats. Redox Biol. 21(101121)2019.PubMed/NCBI View Article : Google Scholar

39 

Lv Y, Liu W, Ruan Z, Xu Z and Fu L: Myosin IIA regulated tight junction in oxygen glucose-deprived brain endothelial cells via activation of TLR4/PI3K/Akt/JNK1/2/14-3-3ε/NF-κB/MMP9 signal transduction pathway. Cell Mol Neurobiol. 39:301–319. 2019.PubMed/NCBI View Article : Google Scholar

40 

Li L, Pan CS, Yan L, Cui YC, Liu YY, Mu HN, He K, Hu BH, Chang X, Sun K, et al: Ginsenoside Rg1 ameliorates rat myocardial ischemia-reperfusion injury by modulating energy metabolism pathways. Front Physiol. 9(78)2018.PubMed/NCBI View Article : Google Scholar

41 

Zhou P, Xie W, He S, Sun Y, Meng X, Sun G and Sun X: Ginsenoside Rb1 as an anti-diabetic agent and its underlying mechanism analysis. Cells. 8(204)2019.PubMed/NCBI View Article : Google Scholar

42 

Wong VK, Dong H, Liang X, Bai LP, Jiang ZH, Guo Y, Kong AN, Wang R, Kam RK, Law BY, et al: Rh2E2, a novel metabolic suppressor, specifically inhibits energy-based metabolism of tumor cells. Oncotarget. 7:9907–9924. 2016.PubMed/NCBI View Article : Google Scholar

43 

Nam Y, Wie MB, Shin E, Nguyen TL, Nah S, Ko SK, Jeong JH, Jang C and Kim H: Ginsenoside Re protects methamphetamine-induced mitochondrial burdens and proapoptosis via genetic inhibition of protein kinase C δ in human neuroblastoma dopaminergic SH-SY5Y cell lines. J Appl Toxicol. 35:927–944. 2015.PubMed/NCBI View Article : Google Scholar

44 

Li J, Liu T, Zhao L, Chen W, Hou H, Ye Z and Li X: Ginsenoside 20(S) Rg3 inhibits the Warburg effect through STAT3 pathways in ovarian cancer cells. Int J Oncol. 46:775–781. 2015.PubMed/NCBI View Article : Google Scholar

45 

Zhou JS, Wang JF, He BR, Cui YS, Fang XY, Ni JL, Chen J and Wang KZ: Ginsenoside Rd attenuates mitochondrial permeability transition and cytochrome C release in isolated spinal cord mitochondria: Involvement of kinase-mediated pathways. Int J Mol Sci. 15:9859–9877. 2014.PubMed/NCBI View Article : Google Scholar

46 

Shangguan WJ, Li H and Zhang YH: Induction of G2/M phase cell cycle arrest and apoptosis by ginsenoside Rf in human osteosarcoma MG 63 cells through the mitochondrial pathway. Oncol Rep. 31:305–313. 2014.PubMed/NCBI View Article : Google Scholar

47 

Zhang C, Cai T, Zeng X, Cai D, Chen Y, Huang X, Gan H, Zhuo J, Zhao Z, Pan H, et al: Astragaloside IV reverses MNNG-induced precancerous lesions of gastric carcinoma in rats: Regulation on glycolysis through miRNA-34a/LDHA pathway. Phytother Res. 32:1364–1372. 2018.PubMed/NCBI View Article : Google Scholar

48 

Dong Z, Zhao P, Xu M, Zhang C, Guo W, Chen H, Tian J, Wei H, Lu R and Cao T: Astragaloside IV alleviates heart failure via activating PPARα to switch glycolysis to fatty acid β-oxidation. Sci Rep. 7(2691)2017.PubMed/NCBI View Article : Google Scholar

49 

Pereira AC, Mao X, Jiang CS, Kang G, Milrad S, McEwen BS, Krieger AC and Shungu DC: Dorsolateral prefrontal cortex GABA deficit in older adults with sleep-disordered breathing. Proc Natl Acad Sci USA. 114:10250–10255. 2017.PubMed/NCBI View Article : Google Scholar

50 

Kwakowsky A, Calvo-Flores Guzmán B, Pandya M, Turner C, Waldvogel HJ and Faull RL: GABAA receptor subunit expression changes in the human Alzheimer's disease hippocampus, subiculum, entorhinal cortex and superior temporal gyrus. J Neurochem. 145:374–392. 2018.PubMed/NCBI View Article : Google Scholar

51 

Jo S, Yarishkin O, Hwang YJ, Chun YE, Park M, Woo DH, Bae JY, Kim T, Lee J, Chun H, et al: GABA from reactive astrocytes impairs memory in mouse models of Alzheimer's disease. Nat Med. 20:886–896. 2014.PubMed/NCBI View Article : Google Scholar

52 

Mayor D and Tymianski M: Neurotransmitters in the mediation of cerebral ischemic injury. Neuropharmacology. 134:178–188. 2018.PubMed/NCBI View Article : Google Scholar

53 

Yu X, Li W, Ma Y, Tossell K, Harris JJ, Harding EC, Ba W, Miracca G, Wang D, Li L, et al: GABA and glutamate neurons in the VTA regulate sleep and wakefulness. Nat Neurosci. 22:106–119. 2019.PubMed/NCBI View Article : Google Scholar

54 

Petroff OA: GABA and glutamate in the human brain. Neuroscientist. 8:562–573. 2002.PubMed/NCBI View Article : Google Scholar

55 

Long H, Ruan J, Zhang M, Wang C and Huang Y: Gastrodin alleviates Tourette syndrome via Nrf-2/HO-1/HMGB1/NF-кB pathway. J Biochem Mol Toxicol. 33(e22389)2019.PubMed/NCBI View Article : Google Scholar

56 

Jiang B, Meng L, Zou N, Wang H, Li S, Huang L, Cheng X, Wang Z, Chen W and Wang C: Mechanism-based pharmacokinetics-pharmacodynamics studies of harmine and harmaline on neurotransmitters regulatory effects in healthy rats: Challenge on monoamine oxidase and acetylcholinesterase inhibition. Phytomedicine. 62(152967)2019.PubMed/NCBI View Article : Google Scholar

57 

Liu J, Wu Y-Y, Yu X-L, Jia HY, Mao QY and Fang JQ: Temporal effect of acupuncture on amino acid neurotransmitters in rats with acute cerebral ischaemia. Acupunct Med. 37:252–258. 2019.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Fu Y, Wei J, Li B, Gao L, Xia P, Wen Y and Xu S: CGA ameliorates cognitive decline by regulating the PI3K/AKT signaling pathway and neurotransmitter systems in rats with multi-infarct dementia. Exp Ther Med 20: 70, 2020.
APA
Fu, Y., Wei, J., Li, B., Gao, L., Xia, P., Wen, Y., & Xu, S. (2020). CGA ameliorates cognitive decline by regulating the PI3K/AKT signaling pathway and neurotransmitter systems in rats with multi-infarct dementia. Experimental and Therapeutic Medicine, 20, 70. https://doi.org/10.3892/etm.2020.9198
MLA
Fu, Y., Wei, J., Li, B., Gao, L., Xia, P., Wen, Y., Xu, S."CGA ameliorates cognitive decline by regulating the PI3K/AKT signaling pathway and neurotransmitter systems in rats with multi-infarct dementia". Experimental and Therapeutic Medicine 20.5 (2020): 70.
Chicago
Fu, Y., Wei, J., Li, B., Gao, L., Xia, P., Wen, Y., Xu, S."CGA ameliorates cognitive decline by regulating the PI3K/AKT signaling pathway and neurotransmitter systems in rats with multi-infarct dementia". Experimental and Therapeutic Medicine 20, no. 5 (2020): 70. https://doi.org/10.3892/etm.2020.9198
Copy and paste a formatted citation
x
Spandidos Publications style
Fu Y, Wei J, Li B, Gao L, Xia P, Wen Y and Xu S: CGA ameliorates cognitive decline by regulating the PI3K/AKT signaling pathway and neurotransmitter systems in rats with multi-infarct dementia. Exp Ther Med 20: 70, 2020.
APA
Fu, Y., Wei, J., Li, B., Gao, L., Xia, P., Wen, Y., & Xu, S. (2020). CGA ameliorates cognitive decline by regulating the PI3K/AKT signaling pathway and neurotransmitter systems in rats with multi-infarct dementia. Experimental and Therapeutic Medicine, 20, 70. https://doi.org/10.3892/etm.2020.9198
MLA
Fu, Y., Wei, J., Li, B., Gao, L., Xia, P., Wen, Y., Xu, S."CGA ameliorates cognitive decline by regulating the PI3K/AKT signaling pathway and neurotransmitter systems in rats with multi-infarct dementia". Experimental and Therapeutic Medicine 20.5 (2020): 70.
Chicago
Fu, Y., Wei, J., Li, B., Gao, L., Xia, P., Wen, Y., Xu, S."CGA ameliorates cognitive decline by regulating the PI3K/AKT signaling pathway and neurotransmitter systems in rats with multi-infarct dementia". Experimental and Therapeutic Medicine 20, no. 5 (2020): 70. https://doi.org/10.3892/etm.2020.9198
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team